Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,064.00
+1.00 (0.09%)
Jan 29, 2026, 5:24 PM IDT
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of 428.17 million as of January 29, 2026. Its market cap has increased by 23.06% in one year.
Market Cap
428.17M
Enterprise Value
10.34M
Revenue
6.62M
Ranking
n/a
PE Ratio
2.95
Stock Price
1,064.00
Market Cap Chart
Since March 19, 2004, Oramed Pharmaceuticals's market cap has increased from 2.37M to 428.17M, an increase of 17,956.12%. That is a compound annual growth rate of 26.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 428.17M | 18.40% |
| Dec 31, 2025 | 361.64M | 1.78% |
| Dec 31, 2024 | 355.33M | 5.88% |
| Dec 29, 2023 | 335.58M | -79.72% |
| Dec 30, 2022 | 1.65B | -2.19% |
| Dec 31, 2021 | 1.69B | 376.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 564.11M |
| Geffen Residence & Renewal | 263.65M |
| Matricelf | 163.97M |
| Clal Biotechnology Industries | 47.99M |
| BioLineRx | 41.77M |
| BioLight Life Sciences | 35.34M |
| Evogene | 29.47M |
| XTL Biopharmaceuticals | 26.49M |